NCT01203267View on ClinicalTrials.gov

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Paclitaxel, Carboplatin

Paclitaxel 80 mg/m2, carboplatin AUC of 2 mg/min/ml, given on days 1, 8 and 15 of a 28-day cycle.

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

Ruijin Hospital

OTHER

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01203267 - Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer | Biotech Hunter | Biotech Hunter